Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

The Effects of Hwalhyulmaksung-bang (Huoxiemoxing-fang) on Membranous Nephropathy Induced by Cationic Bovine Serum Albumin in Mouse Model

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2008, v.29 no.4, pp.68-82



  • Downloaded
  • Viewed

Abstract

Objective: The purpose of our study was to show the effects of Hwalhyulmaksung-bang (Huoxiemoxing-fang, HHMSB) treatment on cBSA-induced in MN Mouse Model. Methods: We divided the 20 mice into 4 groups. One group, named NR, was not treated. The second group, named CT, was treated with cBSA (7㎎/㎏ i.p) only. The third group, named HH-250, was treated with cBSA (7㎎/㎏ i.p) and HHMSB extract (250㎎/㎏, p.o). The fourth group, named HH-500, was treated with cBSA (7㎎/㎏ i.p) and HHMSB extract (500㎎/㎏, p.o). 4 weeks after cBSA, proteinuria, serum albumin, total cholesterol, serum creatinine, BUN, total cell number of spleen and kidney of all groups were measured. CD3e+/CD19+ and CD4+/CD8 cells ratio of peripheral blood, kidney and spleen of all groups were analyzed. IL-1β and TNF-α, IL-6, IgG, IgM, and IFN-γ levels of all groups were gauged. Histological analysis of kidney tissue and immunohistochemical staining (CD4, CD8) of kidney were observed. Results: The level of proteinuria significantly decreased and serum albumin increased in the group treated with cBSA and HHMSB extract compared with the control. Total cholesterol decreased but not significantly. CD3e+/CD19cells ratio of peripheral blood is decreased, but CD4+/CD8cells ratio has no significancy. CD3e+/CD19+ and CD4+/CD8 cells percentage of kidney and spleen has no significancy. Level of IL-1β, IL-6 is significantly decreased, and IFN-γ is significantly increased on HHMSB compared with control. Total IgG level significantly decreased on HHMSB compared with the control. Thickness of GBM decreased on histological analysis of kidney. Deposition of CD4 and CD8 decreased on immunohistochemical staining of kidney. Conclusions: We conclude that Hwalhyulmaksung-bang treatment may could be a useful remedy agents for treating Membranous Neuropathy(MN) induced by cationized bovine serum albumin.

keywords
cationic bovine serum albumin (cBSA), Membranous Nephropathy(MN), Hwalhyulmaksung-bang (Huoxiemoxing-fang, HHMSB)


Reference

1

1. 대한병리학회. 병리학. 서울:고문사. 1997:783-7.

2

2. Bell ET. Renal disease. 2nd ed. Philadelphia: Lea& Febigher. 1950.

3

3. Jones DM. Nephrotic glomerulonephritis. Am J Pathol. 1957;33:313.

4

4. US Renal Data System USRDS 1999 annual data report Bethesda. the National Institute of Health. National Institute of Diabetes and Digestive and Kidney disease. 1999.

5

5. 김기현, 권혁찬, 김문범, 안원석, 감동호, 김상곤, 김성은, 김종성. 신생검증례에 의한 사구체신질환의 분석. 대한내과학회지. 1995;49:674-82.

6

6. 오국환, 안규리, 양재석, 황대연, 이현순, 한진석, 김성권, 이정상. 성인 신증후군의 임상, 병리학적 고찰. 대학내과학회지. 1997;16:254-65.

7

7. Jefferson JA, Couser WG. Therapy of membra- nous nephropathy associated with malignancy and secondary causes. Semin Nephrol 2003;23: 400-5.(663)

8

8. Farquhar MG, Satio A, Kerjaschki D, Orlando RA. The Heymann nephritis antigenic comples: megalin(gp330) and RAp. J Am Soc Nephrol. 1995;6:35-47.

9

9. 김기현. 막성사구체신장염의 원인질환. 대한내과학회지. 1992;43:333-40.

10

10. Cahen R, Francois B, Trolliet P, Gilly J, Parchoux B. Aetiology of membranous glomerulonephritis. a prospective study of 82 adult patients. Nephrol Dial Transplant. 1989:4:172-80.

11

11. Falk RJ, Jennette JC, Nachman PH. Membranous glomerulopathy. In. Brenner BM, eds. Brenner & rector’s the kidney. 6th edition. Philadelphia: WB Saunders company. 1999:1284-92.

12

12. 신현필, 이상호, 이태원, 김명재, 임천규. 특발성 막성 신병증 환자의 치료 결과 및 예후인자 분석. 대한내과학회지. 2004;66:267-74.

13

13. Wasserstain AG. Membrnous glomerulonephritis. J Am Soc Nephrol. 1997;8:664-74.

14

14. 白雲貞, 陳志康. 膜性腎病的中醫臨床與實驗硏究進展. 2001;18(2):53.

15

15. 董興剛. 膜性腎病基本方. 中國中西醫結合新病雜誌. 2003;4(3):134.

16

16. 楡玉壽, 杜嗔亭, 戴敎鎬. 陳以平敎授治療膜性腎病的經驗. 中國中西醫結合新病雜誌. 2004;5(3): 131.

17

17. 陳浚粱, 楊弦洪. 陳以平敎授治療膜性腎炎1例報. 상해중의약잡지. 2001;5:36-7.

18

18. 김재형, 조충식, 김철중. 膜性腎炎方이 Cationized Bovine Serum Albumin투여로 유발된 Mouse의 Membranous Nephropathy에 미치는 영향. 경락경혈학회지. 2007;24(4):163-180.

19

19. 오국환, 안규리, 양재석, 황대연, 이현순, 한진석, 김성권, 이정상. 성인 신증후군의 임상, 병리학적 고찰. 대학내과학회지. 1997;16:254-65.

20

20. Falk RJ, Jennett JC, Nachman PH. membranous nephropathy. In. Brenner BM (ed). The Kidney. Philadelphia:WB Saunders company. 2000:1284 -92.(664)

21

21. Hirayama K, Ebibara I, Yamamoto S et al. Predominance of type-2 immune response in idiopathic membranous nephropathy. Nephron. 2002;91:255-61.

22

22. 대한신장학회. 임상 신장학. 서울:광문출판사. 2001:215-5.

23

23. 김현정, 백주은, 하혜정, 양중일, 함종렬, 장세호, 전은실. 그레이브스 병에 병발한 막성 신병증 1예. 대한내과학회지. 2003;64:130-6.

24

24. Gonazalo A, Mampaso F, Barcena R, Galle해 N, Ortuno J. membranous nephropathy associated with hepatitis B virus infection. long-term clinical and histological outcome. Nephrol dial Transplant. 1999;14:416-8.

25

25. Bhimma R, Coovadia HM. Hepatitis B virus- associated nephropathy. Am J Nephrol. 2004; 24:198-211.

26

26. 대한내과학회편. 해리슨내과학. 서울:도서출판 MIP. 2003:1634-5.

27

27. 張鋒. 黃九香敎授治療特發性膜性腎病的經驗. 中國中西醫結合腎病雜誌. 2002;3(12):68.

28

28. 杜鎬京. 東醫腎系學. 서울:東洋醫學硏究院 出版部. 1993:238-42, 369-77, 393.

29

29. 張天 외. 實用中醫腎病學. 上海:上海中醫學院出版社. 1990:580-90, 831-3.

30

30. 李國賢 외. 164例腎炎患者血液流變學指標及與血瘀證的關係. 中國中西醫結合雜誌. 1993;13:528 -30.

31

31. 李平, 李曜玫. 中草藥腎損害與中醫藥治療. 北京:人民衛生出版社. 2004:310-23.

32

32. 김호철. 한약약리학. 서울:집문당. 2001:227-9, 428-47, 466.

33

33. 李尙仁 외. 本草學. 서울:永林社. 1991:534-6.

34

34. 한종현, 김기영. 한방약리학. 서울:의성당. 2004: 466-87.

35

35. Cattran DC. Membranouse nephropathy. kidney Int. 2002;61:349-50.

36

36. 라신택. 신장학. 서울:의학문화사. 1999:501-5.

37

37. Chen JS, Chen A, Chang LC, Wayne Chang WS, Lee HS, Lin SH, Lin YF. Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences. Nephrol Dial Transplant. 2004;19:2721-8.

38

38. 강재성 외. 세포분자면역학. 서울:범문사. 2004: 480-87.

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Journal of Korean Medicine